Provided by Tiger Trade Technology Pte. Ltd.

PDS Biotechnology Corporation

0.7150
+0.02483.59%
Post-market: 0.73000.0150+2.10%19:45 EST
Volume:449.71K
Turnover:319.58K
Market Cap:37.73M
PE:-0.88
High:0.7409
Open:0.6900
Low:0.6811
Close:0.6902
52wk High:2.20
52wk Low:0.6794
Shares:52.77M
Float Shares:51.41M
Volume Ratio:0.61
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8140
EPS(LYR):-1.0318
ROE:-221.81%
ROA:-46.22%
PB:3.99
PE(LYR):-0.69

Loading ...

Update of Information - Fee and Costs Disclosure in the PDS-GSC

Reuters
·
Jan 30

PDS Biotech Reports Promising Phase 2 Results for PDS01ADC in Metastatic Prostate Cancer

Reuters
·
Jan 28

PDS Biotechnology Receives Notice of Allowance for New U.S. Patent Covering PDS0101 Technology

Reuters
·
Jan 22

BUZZ-PDS Biotech rises as it seeks faster FDA nod for cancer drug

Reuters
·
Jan 09

BRIEF-Pds Biotech Announces FDA Alignment On Use Of Progression Free Survival (Pfs) As Primary Endpoint

Reuters
·
Jan 09

PDS Biotech Submits Amended Phase 3 Trial Protocol for FDA Review

Reuters
·
Jan 09

PDS Biotechnology Corp - Median Overall Survival Remains Primary Endpoint for Full Approval

THOMSON REUTERS
·
Jan 09

PDS Biotech Announces FDA Alignment on Use of Progression Free Survival (Pfs) as Primary Endpoint

THOMSON REUTERS
·
Jan 09

MGOC Replacement PDS-MGO

Reuters
·
Dec 17, 2025

AASF Replacement PDS-AAS

Reuters
·
Dec 17, 2025

CitiFirst Single Stock MINIs Issue 15 Dec 25 PDS-CTW

Reuters
·
Dec 12, 2025

XASG Replacement PDS-XAS

Reuters
·
Dec 11, 2025

PDS Biotechnology Corp - Announces Japan Patent for PDS0101

THOMSON REUTERS
·
Dec 09, 2025

PDS Biotechnology Granted Broad Composition of Matter Patent for PDS0101 in Japan

Reuters
·
Dec 09, 2025

BRIEF-PDS Biotech Announces Scheduling Of Type C Meeting With U.S. Food And Drug Administration

Reuters
·
Dec 02, 2025

PDS Biotechnology Corp - Meeting to Discuss Accelerated Approval for PDS0101

THOMSON REUTERS
·
Dec 02, 2025

PDS Biotech Announces Scheduling of Type C Meeting With U.S. Food and Drug Administration (“FDA”)

THOMSON REUTERS
·
Dec 02, 2025

PRESS DIGEST- New York Times business news - December 2

Reuters
·
Dec 02, 2025

Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB) and Autolus Therapeutics (AUTL)

TIPRANKS
·
Nov 14, 2025

PDS Biotechnology posts Q3 net loss of $9.0 million

Reuters
·
Nov 13, 2025